<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JTR</journal-id><journal-title-group><journal-title>Journal of Tuberculosis Research</journal-title></journal-title-group><issn pub-type="epub">2329-843X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jtr.2023.112008</article-id><article-id pub-id-type="publisher-id">JTR-125763</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Assessment of Prevalence Group A Streptococci (GAS) Associated with Upper Respiratory Tract Infection among Hajj and Umrah Pilgrims
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aiman</surname><given-names>M. Momenah</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>05</month><year>2023</year></pub-date><volume>11</volume><issue>02</issue><fpage>74</fpage><lpage>85</lpage><history><date date-type="received"><day>30,</day>	<month>April</month>	<year>2023</year></date><date date-type="rev-recd"><day>22,</day>	<month>June</month>	<year>2023</year>	</date><date date-type="accepted"><day>25,</day>	<month>June</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Respiratory tract infection (RTI) is a prevalent infection across the world and is a major health concern linked to the crowding that occurs during the Hajj season. Objectives: To identify how prevalent Streptococcus pyogenes is among Umrah visitors and pilgrims by comparing its presence before and after the visitors perform Umrah and hajj. Methods: A cross
  -
  sectional study was carried out 
  on Umrah visitors/pilgrims, for which their throat swabs were taken for assessing the upper respiratory tract infection’s carriage rate, particularly of Group A streptococci (GAS), after they arrived in Saudi Arabia for the Hajj and Umrah rituals and befor their leaving. After collecting the swabs, they were inoculated on Columbia agar using 5% sheep blood and then incubated at 37
  &amp;#730C. VITEK 2 systems were used to identify the isolates. Results: Of the 979/613 Umrah visitors/pilgrims involved, before performing Umrah, their Streptococcus pyogenes percentage was 0.2% and it increased to 0.7 after performing Umrah. Further, the Streptococcus pyogenes percentage before and after performing Hajj was 0.3% and 1.1%, respectively. No statistical significance was found in the difference between the positive Streptococcus pyogenes found before and after performing Hajj and Umrah among Umrah visitors/pilgrims (p-value = 0.2). All bacterial isolates were found to be sensitive to Cefotaxime and Ceftriaxone antibiotics (100%). Conclusion: The Streptococcus pyogeneshigh resistance to antibiotics combined with the lack of a vaccine poses a serious risk concerning the resulting infection spread and emphasizes the necessity of ensuring greater global surveillance of such epidemics.
 
</p></abstract><kwd-group><kwd>Respiratory Tract Infection</kwd><kwd> Pilgrims</kwd><kwd> Streptococcus Pyogenes</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>One of the most well-known gatherings on a global scale, Hajj is attended by approximately more than two million people every year in a generally confined space. The combination of the large number of people from more than 80 countries attending this event with the limited area for them to gather leads to unavoidable overcrowding that can cause numerous infectious diseases to spread during their time in Saudi Arabia [<xref ref-type="bibr" rid="scirp.125763-ref1">1</xref>] . A major health concern linked to crowding is respiratory tract and meningitis infections, which spread easily because of transmission through air droplets [<xref ref-type="bibr" rid="scirp.125763-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref6">6</xref>] . One of the most common infections, respiratory tract infection (RTI) causes an upward of 450 million infections and 4 million deaths every year [<xref ref-type="bibr" rid="scirp.125763-ref7">7</xref>] . RTI is transmitted through respiratory droplets and its risk is increased when there is overcrowding. Individuals can contract this disease from clear symptomatic patients as well as asymptomatic carriers with potentially pathogenic organisms (PPO) including Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Neisseria meningitidis, Moraxella catarrhalis and Haemophilus influenza, Pseudomonas aeruginosa, influenza A and B viruses, parainfluenza 1 - 3 viruses, adenovirus, rhinovirus, and RSV [<xref ref-type="bibr" rid="scirp.125763-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref9">9</xref>] .</p><p>This raises an important issue for the Kingdom of Saudi Arabia (KSA) since it is the country hosting the Islamic religious occasions of Hajj and Umrah. RTI is a severe problem in the KSA because more than 10 million pilgrims visit the country every year for pilgrimage, which also burdens the country’s healthcare sector [<xref ref-type="bibr" rid="scirp.125763-ref10">10</xref>] . Streptococcus pyogenes or Group A streptococci (GAS) is a common bacterial cause of pharyngitis, which involves mild fever, severe sore throat, tonsillar exudates, and enlarged tonsils. There is a greater risk of this infection spreading when there is a large crowd sharing a common environment, thereby resulting in epidemic diseases because of personal contact with infected individuals or even healthy carriers. Pharyngitis is a severe problem because it also involves complications that may arise because of inaccurate diagnosis [<xref ref-type="bibr" rid="scirp.125763-ref11">11</xref>] . Despite the improved economic conditions of developed countries reducing the incidence of diseases in the last 100 years, as evidenced in the living conditions, the pathogenic strains underwent genetic changes that further increased the infection rates. Hence, several epidemiological studies have indicated that these diseases may re-emerge in developed countries [<xref ref-type="bibr" rid="scirp.125763-ref12">12</xref>] .</p><p>The incidence of these infectious diseases will also increase in less developed or poor countries because of the low standard of living resulting from the country’s inadequate economic progress [<xref ref-type="bibr" rid="scirp.125763-ref13">13</xref>] . The present study thus aims to identify the Streptococcus pyogenesprevalence as well as antibiotic resistance patternsin Umrah visitors and pilgrims of varied ethnic groups both before and after performing their Hajj and Umrah.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Collection of Specimens</title><p>For this study, approximately 1958/1226 random samples of throat swabfrom 979/613 Umrah visitors/pilgrims after they arrived in Saudi, followed by samples before they left the countrybetween April 2010 - March 2011. The first set of throat swabs was gathered upon the Umrah visitors/pilgrims’ arrival at King Abdul-Aziz International Airport (KAAIA) along with data forms that included their age, nationality, sex, and other information concerning their coughing, smoking, sore throat, antibiotic usage, and date of sample collection. Samples were collected using Amies Transport Medium to ensure the survival of pathogens in the collected swabs and were then immediately sent to the Microbiology research laboratory at the College of Medicine, Umm Al Qura University.</p></sec><sec id="s2_2"><title>2.2. Cultivation and Identification of Bacteria</title><p>All throat swabs were inoculated on Columbia agar using 5% sheep blood and incubated at 37˚C; overnightincubation. In the second daya small beta-hemolytic colony, Streptococcus pyogenes was isolated from Columbia blood agar, and examined macroscopically based on the characteristic appearance and microscopically, identified as Gram-positive cocci in chains by Gram stain. A catalase test was also performed where catalase-negative. Further, for distinguishing between S. pyogenes (bacitracin sensitive) and other non-group A beta-haemolytic streptococci (bacitracin resistant), more subcultures of beta-haemolytic colonies were carried out on Columbia blood agar using additive bacitracin disc (0.04 IU). VITEK 2 systems compact 15 biomerieux identification, and susceptibility testing (GP ID Cards) were applied to confirm and identify all isolates.</p></sec><sec id="s2_3"><title>2.3. Antibiotic Susceptibility Test</title><p>All isolated strains from throat swabs were subculture on blood agar for antibiotic susceptibility using AST-STO1 card of VITEK II instrument (bioMerieux). Two sterile tubes contain 3 ml saline aqueous 0.45% Na CL, P1-I 7.0 in each tube. In one of these tubes, five colonies were transferred from culture using a sterile stick and mixed to produce a homogenous organism suspension, and the bacterial suspension was adjusted to be equivalent to a McFarland 0.50 using a calibrated VITEK 2 Densicheck. A volume of 280 μl of the bacterial suspension was transferred from the first tube to the second tube. All inoculated cards were placed in the instrument within 30 mm of inoculation. Data were analysed using software version VT2-R4.0l. The results were available within 8 - 12 hours.</p><p>The antibiotic sensitivity test (AST) measured the minimum inhibitor concentrations (MIC) of the following antibiotics against GAS: azithromycin, cefotaxime, ceftriaxone, ciprofloxacin, levofloxacin, erythromycin, vancomycin, augmentin, clindamycin, penicillin, and amoxicillin.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Streptococcus pyogenes Prevalence among Umrah</title><p>The overall prevalence of Streptococcus pyogenes isolated from 979 Umrah visitors during the Umrah season from different nationalities included 129 Turkish, 127 Indonesian, 102 Pakistani, 99 Syrian, 98 Nigerian, 79 Egyptian, 77 Iranian, 71 Indian, 56 British, 56 Iraqi, 39 Malaysian, 27 Libyan, 14 Swedish, 4 American, and 1 Jordanian.</p><p>From the 979 visitors that this study tested, Streptococcus pyogenes were isolated from 0.2% and 0.7% of Umrah visitors before and after performing Umrah, respectively. These isolates were distributed based on their nationalities: One isolate was isolated from Turkish Umrah visitors, 0 before Umrah, and one after Umrah. One isolate was isolated from Syrian Umrah visitors, one before Umrah, and 0 after Umrah. Two isolates were isolated from Indian Umrah visitors, 0 before Umrah, and 2 after Umrah. One isolate was isolated from British Umrah visitors, 0 before Umrah and 1 after Umrah.</p><p>Three isolates were isolated from Iraqi Umrah visitors, 1 before Umrah and 2 after Umrah. One isolate was isolated from Malaysian Umrah visitors, 0 before Umrah and 1 after Umrah. No statistical significance was found for the difference in the positive Streptococcus pyogenes’ prevalence in Umrah visitors before and after performing Umrah (p-value = 0.2) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Rates of infection with Streptococcus pyogenes among Umrah visitors during the Umrah season</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Nationality</th><th align="center" valign="middle"  rowspan="3"  >Number of Umrah visitors</th><th align="center" valign="middle"  colspan="4"  >Before Umrah</th><th align="center" valign="middle"  colspan="4"  >After Umrah</th><th align="center" valign="middle"  rowspan="3"  >P</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >+ Umrah visitors</td><td align="center" valign="middle"  colspan="2"  >− Umrah visitors</td><td align="center" valign="middle"  colspan="2"  >+ Umrah visitors</td><td align="center" valign="middle"  colspan="2"  >− Umrah visitors</td></tr><tr><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Turkish</td><td align="center" valign="middle" >129</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >129</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.78</td><td align="center" valign="middle" >128</td><td align="center" valign="middle" >99.22</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Indonesian</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >127</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Pakistani</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Syrian</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.01</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >98.99</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Nigerian</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Egyptian</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Iranian</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Indian</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.82</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >97.18</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >British</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.79</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >98.21</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Iraqian</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.79</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >98.21</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.57</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >96.43</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Malaysian</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.56</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >97.44</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >Libyan</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Sweden</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >American</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Jordanian</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >979</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.20</td><td align="center" valign="middle" >977</td><td align="center" valign="middle" >99.80</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.72</td><td align="center" valign="middle" >972</td><td align="center" valign="middle" >99.28</td><td align="center" valign="middle" >P = 0.2</td></tr></tbody></table></table-wrap><p>P-value of difference between positive Umrah visitors before performing Umrah and positive Umrah visitors after performing Umrah, P &lt; 0.05 is significant.</p></sec><sec id="s3_2"><title>3.2 Antibiotics Susceptibility Testing of Streptococcus pyogenes</title><p>The study isolated nine Streptococcus pyogenes isolates from Umrah visitors and found them sensitive to Ceftriaxone, Cefotaxime, and Vancomycin antibiotics (<xref ref-type="table" rid="table2">Table 2</xref>).</p>Distribution of Streptococcus pyogenes Prevalence among Pilgrims during the Hajj Season According to Different Nationalities<p>This study tested the prevalence of Streptococcus pyogenes in 613 pilgrims from different nationalities such as 161 Indian, 102 Nigerian, 95 Indonesian, 90 Libyan, 68 Syrian, 46 British, 35 Turkish, 11 Australian, 3 Swedish, and 2 Iranian. The study isolated Streptococcus pyogenes from 0.3% and 1.1% of pilgrims before and after performing Hajj, respectively. These isolates were distributed to various nationalities as follows: Two isolates were isolated from Indian pilgrims, 0 before performing Hajj and 2 after performing Hajj. Two isolates were isolated from Nigerian pilgrims, 0 before performing Hajj and 2 after performing Hajj. Two isolates were isolated from Syrian pilgrims, 2 before performing Hajj and 0 after performing Hajj. Three isolates were isolated from Turkish pilgrims, 0 before performing Hajj and 3 after performing Hajj.</p><p>No statistical significance was found in the difference in the presence of positive Streptococcus pyogenes in pilgrims before and after performing Hajj (p-value = 0.2) (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_3"><title>3.3. Antibiotics Susceptibility Testing of Streptococcus pyogenes Isolated from Pilgrims during the Hajj Season</title><p>The study conducted antibiotics susceptibility testing on the nine Streptococcus pyogenes isolates that were collected from pilgrims and found them all to be sensitive to ceftriaxone, cefotaxime, and vancomycin antibiotics (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Antimicrobial Susceptibility testing of Streptococcus pyogenes isolated from Umrah visitors during the Umrah season</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Antibiotics</th><th align="center" valign="middle"  colspan="4"  >Streptococcus pyogenes isolated before Umrah Total (2)</th><th align="center" valign="middle"  colspan="4"  >Streptococcus pyogenes isolated after Umrah Total (7)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Susceptible</td><td align="center" valign="middle"  colspan="2"  >Non-susceptible</td><td align="center" valign="middle"  colspan="2"  >Susceptible</td><td align="center" valign="middle"  colspan="2"  >Non-susceptible</td></tr><tr><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Azithromycin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >57.14</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.86</td></tr><tr><td align="center" valign="middle" >Cefotaxime</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Ceftriaxone</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Ciprofloxacin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Levofloxacin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Erythromycin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Vancomycin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Augmentin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Clindamycin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Penicillin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Amoxycillin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >57.14</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.86</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Rates of infection with Streptococcus pyogenes among Pilgrims during the Hajj season</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Nationality</th><th align="center" valign="middle"  rowspan="3"  >Number of Pilgrims</th><th align="center" valign="middle"  colspan="4"  >Before Hajj</th><th align="center" valign="middle"  colspan="4"  >After Hajj</th><th align="center" valign="middle"  rowspan="3"  >P</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >+ Pilgrims</td><td align="center" valign="middle"  colspan="2"  >− Pilgrims</td><td align="center" valign="middle"  colspan="2"  >+ Pilgrims</td><td align="center" valign="middle"  colspan="2"  >− Pilgrims</td></tr><tr><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Indian</td><td align="center" valign="middle" >161</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >161</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >159</td><td align="center" valign="middle" >98.8</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Nigerian</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >102</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >Indonesian</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Libyan</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Syrian</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.9%</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >97.1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >British</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Turkish</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >91.4</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >Australian</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Swedish</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Iranian</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >613</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" >611</td><td align="center" valign="middle" >99.7</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >606</td><td align="center" valign="middle" >98.9</td><td align="center" valign="middle" >0.2</td></tr></tbody></table></table-wrap><p>P-value of the difference between positive pilgrims before performing Hajj and positive pilgrims after performing Hajj.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Antimicrobial Susceptibility testing of Streptococcus pyogenes isolated from Pilgrims during the Hajj season</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Antibiotics</th><th align="center" valign="middle"  colspan="4"  >Streptococcus pyogenes isolated before Hajj Total (2)</th><th align="center" valign="middle"  colspan="4"  >Streptococcus pyogenes isolated after Hajj Total (7)</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Susceptible</td><td align="center" valign="middle"  colspan="2"  >Non-susceptible</td><td align="center" valign="middle"  colspan="2"  >Susceptible</td><td align="center" valign="middle"  colspan="2"  >Non-susceptible</td></tr><tr><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >No.</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Azithromycin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Cefotaxime</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Ceftriaxone</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Ciprofloxacin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Levofloxacin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Erythromycin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Vancomycin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Augmentin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >85.71</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Clindamycin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Penicillin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Amoxycillin</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >50.00</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >71.43</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >28.57</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>There are various ways in which Group A streptococci (GAS) is transmitted, such as inhaling droplets directly from another person in a crowd [<xref ref-type="bibr" rid="scirp.125763-ref14">14</xref>] . According to studies, the GAS carrier rate is below 4% in healthy adults [<xref ref-type="bibr" rid="scirp.125763-ref15">15</xref>] . While this percentage increases among children under 15 years of age and reaches between 16 and 18%. Although GAS was discovered many years ago, it still plays an important role in causing illness and death, especially among children and young adults in developed countries [<xref ref-type="bibr" rid="scirp.125763-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref18">18</xref>] . While GAS was discovered several years ago, it continues to be a major cause of illness and death, particularly in children and young adults in developed countries [<xref ref-type="bibr" rid="scirp.125763-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref22">22</xref>] . Studies have also noted that this disease is more prevalent in poor communities because of the low economic and social conditions that hinder their inability to afford health care costs [<xref ref-type="bibr" rid="scirp.125763-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref25">25</xref>] . Other studies have shown that nearly 18.1 million people suffer from a serious GAS disease presently, that 1.78 million new cases and 500,000 deaths occur annually in 110 low- and middle-income countries, and that the disease is endemic in developed countries disadvantaged groups [<xref ref-type="bibr" rid="scirp.125763-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref27">27</xref>] .</p><p>In the present study, Streptococcus pyogenes were isolated from 0.2% and 0.7% Umrah visitors before and after they performed Umrah, respectively. The 979 Umrah visitors were from diverse countries such as Turkey, Indonesia, Pakistan, Syria, Nigeria, Egypt, Iran, India, Britain, Iraq, Malaysia, Libya, Sweden, America, and Jordan. The difference in the positive Streptococcus pyogenesprevalencefound in Umrah visitors before and following them performing Umrah did not have statistical significance (p-value = 0.2). Of the 979 Umrah visitors, 129 Turkish visitors had a 0-carrier rate of the potentially pathogenic bacteria before performing Umrah, which increased to 1 (0.8%) after performing Umrah, and this difference did not have statistical significance (p-value = 1.0). From the Indonesian and Pakistani Umrah visitors, no Streptococcus pyogenes were isolated before or after performing Umrah. Of the 979 Umrah Visitors, 99 Syrian visitors were 1% positive and 0% positive for potentially pathogenic bacteria before and after performing Umrah, respectively, and this difference did not have statistical significance (p-value = 1.0). Next, the 56 Iraqi visitors were 1% and 3.5% positive for potentially pathogenic bacteria before and after performing Umrah, respectively. For the 39 Malaysian visitors, 0% and 2.5% were positive for Streptococcus pyogenes before and after performing Umrah, respectively, and this difference did not have a statistical significance (p-value = 0.4). For the 27 Libyan, 14 Swedish, 4 American, and 1 Jordanian visitors, no Streptococcus pyogenes were isolated before or after performing Umrah.</p><p>Streptococcus pyogenes were isolated from 613 pilgrims during the Hajj season from 0.3% before performing Hajj and 1.1% after performing Hajj. No statistical significance was found in the difference in the presence of positive Streptococcus pyogenes in pilgrims before and after performing Hajj (p-value = 0.2).</p><p>The present study involved 1226 samples (two swabs from every pilgrim, once upon arrival in Saudi Arabia, and once before they departed from Saudi Arabia) gathered from 613 pilgrims from various countries including India, Nigeria, Indonesia, Libya, Syria, Britain, Turkey, Australia, Sweden, and Iran. The 161 Indian pilgrims showed a 0% carrier rate of the potentially pathogenic bacteria before performing Hajj and a 1.2% carrier rate after performing Hajj, and this difference had no statistical significance (p-value = 0.4). The 102 Nigerian pilgrims were a 0% and 2% positive for the potentially pathogenic bacteria before and after performing Hajj, respectively, and this difference had no statistical significance (p-value = 0.5). The 68 Syrian pilgrims were 2.9% and 0% positive for Streptococcus pyogenes before and after performing Hajj, respectively, and this difference did not have statistical significance (p-value = 0.5). Out of the 613 pilgrims selected in this study, 0 (0%) were positive for Streptococcus pyogenes before performing Hajj and 3 (8.6%) were positive after performing Hajj and this difference was not statistically significant (p-value = 0.2).</p><p>Further, for the 95 Indonesian pilgrims, 90 Libyan pilgrims, 46 British pilgrims, 3 Swedish pilgrims, and 2 Iranian pilgrims, no Streptococcus pyogenes were isolated before or after performing Hajj. The present study found that Cefotaxime, Ceftriaxone, and Vancomycin antibiotics were the most effective against Streptococcus pyogenes, while Amoxycillin had the lowest efficiency. The study further noted that only a few countries had systematic monitoring systems and comprehensive data concerning Streptococcus pyogenes infection (pharyngitis) outbreaks [<xref ref-type="bibr" rid="scirp.125763-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref30">30</xref>] . Thus, regular assessments are crucial for monitoring infection trends in seasons that involve large gatherings in crowded places [<xref ref-type="bibr" rid="scirp.125763-ref31">31</xref>] . Numerous studies have affirmed that the GAS genetic diversity is a major factor that has made this bacterial infection persistent in all countries, although its percentage differs in different countries based on the environmental, economic development, living conditions, health care, and efforts made for addressing the spread of epidemic across the world [<xref ref-type="bibr" rid="scirp.125763-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref33">33</xref>] .</p><p>Antibiotics are necessary for treatment because complications may occur from an untreated infection. untreated pharyngitis could lead to scarlet fever [<xref ref-type="bibr" rid="scirp.125763-ref34">34</xref>] . This results in rheumatic heart disease, a chronic condition that is a major cause of GAS morbidity and mortality [<xref ref-type="bibr" rid="scirp.125763-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.125763-ref36">36</xref>] . The risk of these complications is limited when GAS infections are rapidly treated. penicillin is the gold standard of antibiotic treatment for many GAS infections [<xref ref-type="bibr" rid="scirp.125763-ref37">37</xref>] . β-lactams target penicillin-binding proteins (PBPs) to block peptidoglycan cross-linking in metabolically active bacteria, leading to bacterial death [<xref ref-type="bibr" rid="scirp.125763-ref38">38</xref>] . This study has some limitations. This study was conducted on fifteen nationalities only due to the extreme crowding during the Hajj season and the limited research resources. However, this study gave indications about the level of infection transmission before and after performing Hajj and Umrah. This study, therefore, recommends further research in this field during the Hajj, and Umrah seasons to address other aspects that this study was unable to focus on. This study, therefore, emphasized this type of bacterial pathogen given its prevalence in the Hajj and Umrah seasons and recommend further research in this field during the Hajj, and Umrah seasons to address other aspects that this study was unable to focus on.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The Streptococcus pyogenes carrier rate was 0.2% and 0.7% before and after performing Umrah, respectively, and 0.3% and 1.1% before and after performing Hajj, respectively. It was noted that the Iraqi Umrah visitors were the most ethnic group that carried Streptococcus pyogenes prior to performing Umrah at 1.7% and after performing Umrah at 3.6%. Moreover, the Syrian pilgrims were the ethnic group carrying Streptococcus pyogenes before performing Hajj at 2.9%, whereas the Turkish pilgrims were the ethnic group carrying Streptococcus pyogenes after performing Hajj at 8.6%. The study found Cefotaxime, Ceftriaxone and Vancomycin antibiotics to be most effective against Streptococcus pyogenes isolated from Umrah visitors and pilgrims. These results can thus help medical decision-makers to determine the carriage prevalence of these pathogenic bacteria and develop epidemiological information regarding the microbial respiratory tract carriage while assessing the existing antibiotics design and policy and implement the necessary prophylactic and treatment measures. This bacteria’s increasing resistance to antibiotics and the lack of a vaccine pose a serious threat in terms of the spread of infection and emphasizes the need for better global surveillance of these epidemics.</p></sec><sec id="s6"><title>Acknowledgements</title><p>I thank the entire staff at the department of Microbiology, Faculty of Medicine Umm Al-Qura University for their efforts in carrying out this study. I also express my gratitude to the students of the 3rd year in the Faculty of Medicine and 2nd and 3rd year in the Faculty of Applied Medical Science Umm Al-Qura University for their efforts in sample collection and sample transport. I would like to thank the Center of Excellence at Custodian of the Two Holy Mosques Institute for Hajj and Umrah Research, Umm Al-Qura University Makkah, Saudi Arabia for funding this research.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Declarations</title><p>Ethics approval was obtained from the Ethics Committee of the Faculty of Medicine.</p></sec><sec id="s9"><title>Cite this paper</title><p>Momenah, A.M. (2023) Assessment of Prevalence Group A Streptococci (GAS) Associated with Upper Respiratory Tract Infection among Hajj and Umrah Pilgrims. Journal of Tuberculosis Research, 11, 74-85. https://doi.org/10.4236/jtr.2023.112008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.125763-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Benkouiten, S., Al-Tawfiq, J.A., Memish, Z.A., Albarrak, A. andGautret, P. (2019) Clinical Respiratory Infections and Pneumonia during the Hajj Pilgrimage: A Systematic Review. Travel Medicine and Infectious Disease, 28, 15-26. https://doi.org/10.1016/j.tmaid.2018.12.002</mixed-citation></ref><ref id="scirp.125763-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Alqahtani, A.S., Tashani, M., Heywood, A.E., Almohammed, A.B.S., Booy, R., Wiley, K.E. and Rashid, H. (2020) Tracking Australian Hajj Pilgrims’ Health Behavior before, during and after Hajj, and the Effective Use of Preventive Measures in Reducing Hajj-Related Illness: A Cohort Study. Pharmacy, 4, Article 78. https://doi.org/10.3390/pharmacy8020078</mixed-citation></ref><ref id="scirp.125763-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Sridhar, S., Lagier, J.C. and Gautret, P. (2017) Respiratory Tract Infection in a Traveler Returning from the Hajj. Infectious Diseases, 2, 1132-1133. https://doi.org/10.1016/B978-0-7020-6285-8.00228-8</mixed-citation></ref><ref id="scirp.125763-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Al-Tawfiq, J.A., Gautret, P., Benkouiten, S. and Memish, Z.A. (2016) Mass Gatherings and the Spread of Respiratory Infections. Lessons from the Hajj. Annals of the American Thoracic Society, 13, 759-765. https://doi.org/10.1513/AnnalsATS.201511-772FR</mixed-citation></ref><ref id="scirp.125763-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Annan, A., et al. (2015) High Prevalence of Common Respiratory Viruses and No Evidence of Middle East Respiratory Syndrome Coronavirus in Hajj Pilgrims Returning to Ghana, 2013. Tropical Medicine &amp; International Health, 20, 807-812. https://doi.org/10.1111/tmi.12482</mixed-citation></ref><ref id="scirp.125763-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Azeem, M.I., et al. (2017) Surveillance of Australian Hajj Pilgrims for Carriage of Potentially Pathogenic Bacteria: Data from Two Pilot Studies. World Journal of Clinical Cases, 5, 102-111. https://doi.org/10.12998/wjcc.v5.i3.102</mixed-citation></ref><ref id="scirp.125763-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gherardi, G., Vitali, L.A. and Creti, R. (2018) Prevalent emm Types among Invasive GAS in Europe and North America since Year 2000. Frontiers in Public Health, 6, Article 59. https://doi.org/10.3389/fpubh.2018.00059</mixed-citation></ref><ref id="scirp.125763-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Watts, V., Balasegaram, S., Brown, C.S., Mathew, S., Mearkle, R., Ready, D., et al. (2019) Increased Risk for Invasive Group A Streptococcus Disease for Household Contacts of Scarlet Fever Cases, England, 2011-2016. Emerging Infectious Diseases, 25, 529-537. https://doi.org/10.3201/eid2503.181518</mixed-citation></ref><ref id="scirp.125763-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kadioglu, A., Weiser, J.N., Paton, J.C. and Andrew, P.W. (2008) The Role of Streptococcus pneumoniae Virulence Factors in Host Respiratory Colonization and Disease. Nature Reviews Microbiology, 6, 288-301. https://doi.org/10.1038/nrmicro1871</mixed-citation></ref><ref id="scirp.125763-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gautret, P., Benkouiten, S., Al-Tawfiq, J.A. and Memish, Z.A. (2016) Hajj-Associated Viral Respiratory Infections: A Systematic Review. Travel Medicine and Infectious Disease, 14, 92-109. https://doi.org/10.1016/j.tmaid.2015.12.008</mixed-citation></ref><ref id="scirp.125763-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Nelson, G.E., et al. (2016) Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. Reviews of Infectious Diseases, 63, 478-486. https://doi.org/10.1093/cid/ciw248</mixed-citation></ref><ref id="scirp.125763-ref12"><label>12</label><mixed-citation publication-type="book" xlink:type="simple">Ralph, A.P. and Carapetis, J.R. (2012) Group A Streptococcal Diseases and Their Global Burden. In: Chhatwal, G., Ed., Host-Pathogen Interactions in Streptococcal Diseases, Current Topics in Microbiology and Immunology, Vol. 368, Springer, Berlin, 1-27. https://doi.org/10.1007/82_2012_280</mixed-citation></ref><ref id="scirp.125763-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Rudolph, K., et al. (2016) Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013. Journal of Clinical Microbiology, 54, 134-141. https://doi.org/10.1128/JCM.02122-15</mixed-citation></ref><ref id="scirp.125763-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Barnett, T., Bowen, A. and Carapetis, J.R. (2019) The Fall and Rise of Group A Streptococcus Diseases. Epidemiology &amp; Infection, 147, E4. https://doi.org/10.1017/S0950268818002285</mixed-citation></ref><ref id="scirp.125763-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Barth, D., et al. (2019) Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town. mSphere, 4, e00421-19. https://doi.org/10.1128/mSphere.00421-19</mixed-citation></ref><ref id="scirp.125763-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kemble, S.K., et al. (2013) Foodborne Outbreak of Group A Streptococcus Pharyngitis Associated with a High School Dance Team Banquet—Minnesota, 2012. Clinical Infectious Diseases, 57, 648-654. https://doi.org/10.1093/cid/cit359</mixed-citation></ref><ref id="scirp.125763-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Centor, R.M., Atkinson, T.P., Ratliff, A.E., Xiao, L., Crabb, D.M., Estrada, C.A., Faircloth, M.B., Oestreich, L., Hatchett, J., Khalife, W. and Waites, K.B. (2015) The Clinical Presentation of Fusobacterium-Positive and Streptococcal-Positive Pharyngitis in a University Health Clinic: A Cross-Sectional Study. Annals of Internal Medicine, 162, 241-247. https://doi.org/10.7326/M14-1305</mixed-citation></ref><ref id="scirp.125763-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Steer, J.A., et al. (2012) Guidelines for Prevention and Control of Group A Streptococcal Infection in Acute Healthcare and Maternity Settings in the UK. Journal of Infection, 64, 1-18. https://doi.org/10.1016/j.jinf.2011.11.001</mixed-citation></ref><ref id="scirp.125763-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sanyahumbi, A.S., et al. (2016) Global Disease Burden of Group A Streptococcus. Streptococcus Pyogenes: Basic Biology to Clinical Manifestations, University of Oklahoma Health Sciences Center, Oklahoma City.</mixed-citation></ref><ref id="scirp.125763-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Barth, D.D., et al. (2015) Prevalence of Group A Streptococcal Disease in North and Sub-Saharan Africa: A Systematic Review Protocol. BMJ Open, 5, e008646. https://doi.org/10.1136/bmjopen-2015-008646</mixed-citation></ref><ref id="scirp.125763-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Shapiro, D.J., King, L.M., Fleming-Dutra, K.E., Hicks, L.A. and Hersh, A.L. (2020) Association between Use of Diagnostic Tests and Antibiotic Prescribing for Pharyngitis in the United States. Infection Control &amp; Hospital Epidemiology, 41, 479-481. https://doi.org/10.1017/ice.2020.29</mixed-citation></ref><ref id="scirp.125763-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Vazquez, M.N. and Sanders, J.E. (2017) Diagnosis and Management of Group A Streptococcal Pharyngitis and Associated Complications. Pediatric Emergency Medicine Practice, 14, 1-20.</mixed-citation></ref><ref id="scirp.125763-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Zakikhany, K., et al. (2011) Increase in Invasive Streptococcus Pyogenes and Streptococcus Pneumoniae Infections in England, December 2010 to January 2011. Eurosurveillance, 16, Article ID: 19785. https://doi.org/10.2807/ese.16.05.19785-en</mixed-citation></ref><ref id="scirp.125763-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Yoo, T.K., Choi, J.Y., Jang, Y., Oh, E. and Ryu, I.H. (2020) Toward Automated Severe Pharyngitis Detection with Smartphone Camera Using Deep Learning Networks. Computers in Biology and Medicine, 125, Article ID: 103980. https://doi.org/10.1016/j.compbiomed.2020.103980</mixed-citation></ref><ref id="scirp.125763-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Francis, J.R., et al. (2019) A Cluster of Acute Rheumatic Fever Cases among Aboriginal Australians in a Remote Community with High Baseline Incidence. Australian and New Zealand Journal of Public Health, 43, 288-293. https://doi.org/10.1111/1753-6405.12893</mixed-citation></ref><ref id="scirp.125763-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Oliver, J.R., et al. (2017) Acute Rheumatic Fever and Exposure to Poor Housing Conditions in New Zealand: A Descriptive Study. Journal of Paediatrics and Child Health, 53, 358-364. https://doi.org/10.1111/jpc.13421</mixed-citation></ref><ref id="scirp.125763-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Shetty, A., Mills, C. and Eggleton, K. (2014) Primary Care Management of Group A Streptococcal Pharyngitis in Northland. Journal of Primary Health Care, 6, 189-194. https://doi.org/10.1071/HC14189</mixed-citation></ref><ref id="scirp.125763-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Dick, K. and Schneider, J. (2021) Economic Evaluation of FebriDx&amp;#174: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States. Journal of Health Economics and Outcomes Research, 8, 56-62. https://doi.org/10.36469/jheor.2021.27753</mixed-citation></ref><ref id="scirp.125763-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Kumar, R., et al. (2014) Streptococcal Pharyngitis, Rheumatic Fever and Rheumatic Heart Disease: Eight-Year Prospective Surveillance in Rupnagar District of Punjab, India. The National Medical Journal of India, 27, 70-75.</mixed-citation></ref><ref id="scirp.125763-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Mosites, E., et al. (2018) Outbreak of Invasive Infections from Subtype emm26. 3 group A Streptococcus among Homeless Adults—Anchorage, Alaska, 2016-2017. Clinical Infectious Diseases, 66, 1068-1074. https://doi.org/10.1093/cid/cix921</mixed-citation></ref><ref id="scirp.125763-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Cummins, A., Millership, S., Lamagni, T. and Foster, K. (2012) Control Measures for Invasive Group A Streptococci (iGAS) Outbreaks in Care Homes. Journal of Infection, 64, 156-161. https://doi.org/10.1016/j.jinf.2011.11.017</mixed-citation></ref><ref id="scirp.125763-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">May, P.J., Bowen, A.C. and Carapetis, J.R. (2016) The Inequitable Burden of Group A Streptococcal Diseases in Indigenous Australians. Medical Journal of Australia, 205, 201-203. https://doi.org/10.5694/mja16.00400</mixed-citation></ref><ref id="scirp.125763-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Saavedra-Campos, M., et al. (2017) Estimating the Risk of Invasive Group A Streptococcus Infection in Care Home Residents in England, 2009-2010. Epidemiology &amp; Infection, 145, 2759-2765. https://doi.org/10.1017/S0950268817001674</mixed-citation></ref><ref id="scirp.125763-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Davies, M.R., Holden, M.T., Coupland, P., Chen, J.H.K., Venturini, C., Barnett, T.C., et al. (2015) Emergence of Scarlet Fever Streptococcus pyogenes emm12 Clones in Hong Kong Is Associated with Toxin Acquisition and Multidrug Resistance. Nature Genetics, 47, 84-87. https://doi.org/10.1038/ng.3147</mixed-citation></ref><ref id="scirp.125763-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Park, D.W., Kim, S.-H., Park, J.W., Kim, M.-J., Cho, S.J., Park, H.J., et al. (2017) Incidence and Characteristics of Scarlet Fever, South Korea, 2008-2015. Emerging Infectious Diseases, 23, 658-661. https://doi.org/10.3201/eid2304.160773</mixed-citation></ref><ref id="scirp.125763-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Lynskey, N.N., Jauneikaite, E., Li, H.K., Zhi, X., Turner, C.E., Mosavie, M., et al. (2019) Emergence of Dominant Toxigenic M1T1 Streptococcus pyogenes Clone during Increased Scarlet Fever Activity in England: A Population-Based Molecular Epidemiological Study. The Lancet Infectious Diseases, 19, 1209-1218. https://doi.org/10.1016/S1473-3099(19)30446-3</mixed-citation></ref><ref id="scirp.125763-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Carapetis, J.R., Steer, A.C., Mulholland, E.K. and Weber, M. (2005) The Global Burden of Group a Streptococcal Diseases. The Lancet Infectious Diseases, 5, 685-694. https://doi.org/10.1016/S1473-3099(05)70267-X</mixed-citation></ref><ref id="scirp.125763-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Stevens, D.L., Bisno, A.L., Chambers, H.F., Dellinger, E.P., Goldstein, E.J.C., Gorbach, S.L., et al. (2014) Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 59, e10-e52. https://doi.org/10.1093/cid/ciu296</mixed-citation></ref></ref-list></back></article>